# Tigenix NV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tigenix

- Industry: Biotechnology
- Headquarters: Leuven, Belgium
- Website: www.tigenix.com
- Total disclosed funding: $33M
- Latest round: Series B (Jan 5, 2006)
- Investors on record: 11

## About

Founded in 2000 and based in Leuven, Belgium, Tigenix NV is a public biomedical company that focuses on ‘Regenerating Motion’. The company is exploiting the power of Regenerative Medicine to develop durable treatments, validated through controlled clinical trials, for damaged and diseased skeletal tissues.

## Funding rounds

- Series B, Jan 5, 2006, $19M — Auriga Partners, Capricorn Partners, Banque de Luxembourg, ITX Corporation, Société Régionale d'Investissement de Wallonie, Baekeland Fonds, ING Wholesale Banking, HSS Ventures, Partners At Venture NV
- Series A, Oct 1, 2003, $14M — Auriga Partners, Capricorn Partners, K.U. Leuven Research & Development, ING Capital

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A, Series B
- Capricorn Partners (https://capitalatlas.ai/funds/capricorn-partners) — Series A, Series B
- K.U. Leuven Research & Development (https://capitalatlas.ai/funds/k-u-leuven-research-development) — Series A
- ING Capital — Series A
- Banque de Luxembourg (https://capitalatlas.ai/funds/banque-de-luxembourg) — Series B
- ITX Corporation — Series B
- Société Régionale d'Investissement de Wallonie — Series B
- Baekeland Fonds (https://capitalatlas.ai/funds/baekeland-fonds) — Series B
- ING Wholesale Banking (https://capitalatlas.ai/funds/ing-wholesale-banking) — Series B
- HSS Ventures — Series B
- Partners At Venture NV — Series B